| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3864734 | The Journal of Urology | 2013 | 6 Pages |
Abstract
Plasmacytoid urothelial carcinoma is an aggressive subset with overall poor outcomes. Although down staging is seen with neoadjuvant chemotherapy, there are few long-term survivors. There is a strong predilection for recurrence along the peritoneal lining.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Farshid Dayyani, Bogdan A. Czerniak, Kanishka Sircar, Mark F. Munsell, Randall E. Millikan, Colin P. Dinney, Arlene O. Siefker-Radtke,